Simone Berardozzi

Dr. Simone Berardozzi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Pharmacological Research
Verified
Journal Article
Closed access
BCBuse Cevatemre
Buse Cevatemre
MEMerve Erkısa
Merve Erkısa
NANazlihan Aztopal
Nazlihan Aztopal
Didem KarakasDidem Karakas
Didem Karakas
PAPınar Alper
Pınar Alper
EUEngin Ulukaya
Engin Ulukaya

19 January 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Andrea CalcaterraAndrea Calcaterra
Andrea Calcaterra
LMLaura Mangiardi
Laura Mangiardi
GMGiuliano Delle Monache
Giuliano Delle Monache
Deborah QuaglioDeborah Quaglio
Deborah Quaglio
SBSilvia Balducci
Silvia Balducci
Francesca GhirgaFrancesca Ghirga
Francesca Ghirga
The Pictet-Spengler reaction (P-S) is one of the most direct, efficient, and variable synthetic method for the construction of privileged pharmacophores such as tetrahydro-isoquinolines (THIQs), tetrahydro-β-carbolines (THBCs), and polyheterocyclic frameworks. In the lustro (five-year period) following its centenary birthday, the P-S reaction did not exit the stage but it came up again on limelight with new features. This review focuses on the interesting results achieved in this period (2011–2015), analyzing the versatility of this reaction. Classic P-S was reported in the total synthesis of complex alkaloids, in combination with chiral catalysts as well as for the generation of libraries of compounds in medicinal chemistry. The P-S has been used also in tandem reactions, with the sequences including ring closing metathesis, isomerization, Michael addition, and Gold- or Brønsted acid-catalyzed N-acyliminium cyclization. Moreover, the combination of P-S reaction with Ugi multicomponent reaction has been exploited for the construction of highly complex polycyclic architectures in few steps and high yields. The P-S reaction has also been successfully employed in solid-phase synthesis, affording products with different structures, including peptidomimetics, synthetic heterocycles, and natural compounds. Finally, the enzymatic version of P-S has been reported for biosynthesis, biotransformations, and bioconjugations.

1 August 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SBSimone Berardozzi
Simone Berardozzi
FBFlavia Bernardi
Flavia Bernardi
PIPaola Infante
Paola Infante
Cinzia IngallinaCinzia Ingallina
Cinzia Ingallina
STSara Toscano
Sara Toscano
FGFrancesca Ghirga
Francesca Ghirga

29 March 2016 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
Cinzia IngallinaCinzia Ingallina
Cinzia Ingallina
IDIlaria D'Acquarica
Ilaria D'Acquarica
GMGiuliano Delle Monache
Giuliano Delle Monache
FGFrancesca Ghirga
Francesca Ghirga
DQDeborah Quaglio
Deborah Quaglio
Bruno BottaBruno Botta
Bruno Botta
Today, in spite of being older than a century (born in 1911), the Pictet-Spengler two component reaction (PS-2CR) is still one of the most popular reactions, not only for the synthesis of tetrahydroisoquinolines (THIQs), tetrahydro-β-carbolines (THBCs), or more complex structures containing these two privileged moieties, but also for the construction of novel scaffolds, available for structure-activity relationship (SAR) studies and/or for combinatorial libraries targeted at drug discovery. The prominence of the P-S cyclization is brought about by the inheritance from analogous enzyme-catalyzed reactions of the biogenetic pathways of natural products, mainly indole alkaloids, with a broad range of biological activities. This knowledge has been the starting point for the biomimetic synthesis or the bio-engineering production of pharmacologically important drugs. The long-lasting life of the P-S reaction depends on the discovery of its multiple facets, the modifications of its parameters and components, as well as the continuous renovation of solutions for the challenging stereochemical outcome of the transformation. This paper deals with an updated visit to the P-S reaction aiming to find the threads of the story without forgetting the numerous facets of the prism. It is organized as a theater piece, with a prologue and the main scene (namely, Act 1) where the readers can follow the parade of the two above-mentioned very recurring motifs (namely, THIQ and THBC) by moving from one step to another (a cyclization, an intramolecular attack, a stereoselective passage) to find the way out of the labyrinth of the P-S reaction.

21 March 2017 in Nanomedicine
Verified
Journal Article
Open access
Cinzia IngallinaCinzia Ingallina
Cinzia Ingallina
PCPedro M Costa
Pedro M Costa
FGFrancesca Ghirga
Francesca Ghirga
RKRebecca Klippstein
Rebecca Klippstein
JWJulie T Wang
Julie T Wang
KAKhuloud T. Al-Jamal
Khuloud T. Al-Jamal
Aim: With the purpose of delivering high doses of glabrescione B (GlaB) to solid tumors after systemic administration, long-circulating GlaB-loaded oil-cored polymeric nanocapsules (NC-GlaB) were formulated. Materials & methods: Synthesis of GlaB and its encapsulation in nanocapsules (NCs) was performed. Empty and GlaB-loaded NCs were assessed for their physico-chemical properties, in vitro cytotoxicity and in vivo biodistribution. Results: GlaB was efficiently loaded into NCs (∽90%), which were small (∽160 nm), homogeneous and stable upon storage. Further, GlaB and NC-GlaB demonstrated specific activities against the cancer stem cells. Preliminary studies in tumor-bearing mice supported the ability of NC to accumulate in pancreatic tumors. Conclusion: This study provides early evidence that NC-GlaB has the potential to be utilized in a preclinical setting and justifies the need to perform therapeutic experiments in mice.

29 March 2016 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
VIValentina Iovine
Valentina Iovine
MMMattia Mori
Mattia Mori
Andrea CalcaterraAndrea Calcaterra
Andrea Calcaterra
SBSimone Berardozzi
Simone Berardozzi
Bruno BottaBruno Botta
Bruno Botta
The natural steroidal alkaloid cyclopamine has been identified as the first inhibitor of the Hedgehog (Hh) signaling pathway, which is implicated in embryonic development and tumorigenesis, as well as is hyperactivated in cancer stem cells (CSCs). The list of Hh-dependent tumors is steadily growing, and it has been estimated that about 25% of all cancer deaths show signs of aberrant Hh pathway activation. Notably, cyclopamine has been found to exert anticancer activity against several types of human cancer and to inhibit CSCs proliferation, thus highlighting the druggability of the Hh pathway and paving new opportunities in anticancer drug discovery. The aim of the present work is to review the main synthetic strategies to cyclopamine and its derivatives, with particular emphasis on the challenging chemical modifications aimed at improving the biological activity of the molecule.